Reversal of diet-induced obesity and insulin resistance by inducible genetic ablation of GRK2

Authors:

Abstract
Inhibiting a protein involved in insulin and adrenergic signaling may improve metabolic disorders.
Funding Information
  • Ministerio de Economía y Competitividad (MINECO) (SAF2014-55511-R)
  • INDISNET (S2010/BMD-2332)
  • Ministerio Sanidad y Consumo-Instituto Carlos III, Spain (RD12/0042/0012)
  • European Foundation for the Study of Diabetes Novo Nordisk Partnership for Diabetes Research in Europe
  • Fundación Ramón Areces
  • National Institute of Neurological Disorders and Stroke
  • NIH (RO1NS073939, RO1NS074999)

This publication has 66 references indexed in Scilit: